Definium Therapeutics, Inc. (DFTX)

Definium Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 24, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,719	510	147	83	590	3,449
Market Cap Growth	161.33%	247.80%	77.54%	-85.99%	-82.89%	-
Enterprise Value	1,551	239	43	-72	444	3,430
Last Close Price	17.45	6.96	3.66	2.20	20.70	45.75
PB Ratio	10.26	2.11	1.88	0.55	3.89	45.45
P/TBV Ratio	15.53	2.30	2.54	0.65	4.73	45.45
Debt / Equity Ratio	0.31	0.09	0.18	-	-	-
Net Debt / Equity Ratio	-1.29	-1.04	-1.09	-0.94	-0.88	-1.06
Net Debt / EBITDA Ratio	1.11	2.42	-	2.14	1.43	2.47
Quick Ratio	3.20	7.05	3.09	7.94	12.83	26.63
Current Ratio	3.30	7.25	3.22	8.16	13.18	27.10
Return on Equity (ROE)	-85.59%	-68.01%	-83.59%	-37.54%	-81.78%	-79.04%
Return on Assets (ROA)	-33.95%	-30.44%	-39.84%	-24.82%	-47.63%	-44.17%
Return on Capital Employed (ROCE)	-88.20%	-39.50%	-101.70%	-43.60%	-60.90%	-42.10%
Earnings Yield	-9.78%	-21.29%	-65.24%	-68.71%	-15.76%	-0.98%
Buyback Yield / Dilution	-42.97%	-79.94%	-26.90%	-12.71%	-54.25%	-159.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.